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Cluster randomised trials with repeated cross sections: 
alternatives to parallel group designs
Richard Hooper,1 Liam Bourke2 
Clinical trials need not use parallel 
group designs to assess the efect of an 
intervention. This article considers 
alternative designs for cluster 
randomised trials with repeated cross 
sections that could reduce the number 
of clusters and participants required
In 1948, the UK Medical Research Council’s streptomycin 
trial established the principles of the modern clinical trial,1 
and for longer still the idea of a comparison group 
recruited concurrently to the intervention group has been 
recognised as essential to obtaining sound evidence for 
clinical efectiveness.2  But must a trial proceed by running 
an intervention and comparator in parallel? In this article, 
we focus on trials where participants are randomised in 
clusters such as general practices or schools. This format 
is common when evaluating interventions applied at clus-
ter level.3 We look at trials where the comparator is routine 
care, which efectively ask how individuals’ outcomes 
would compare before and after introducing the interven-
tion in a cluster. We discuss eicient alternatives to paral-
lel group trial designs in this case—made possible by 
delaying introduction of the intervention in some clusters 
after randomisation, with these clusters continuing in the 
meantime to receive routine care.
Example study 
Murphy and colleagues evaluated a free school break-
fast programme in Wales using a cluster randomised 
trial with schools as clusters.4  At each of the 111 schools, 
a baseline sample of about 50 children aged 9-11 years 
completed assessments of behaviour, cognitive perfor-
mance, and diet. Half the schools were randomised to 
receive the intervention. One year later, a new sample of 
children aged 9-11 years was taken at each school. 
Because a diferent sample of children was taken on 
each occasion, we would describe the design as involv-
ing repeated cross sections.5  We refer to the particular 
design used by Murphy and colleagues as a parallel 
group design with a baseline assessment (ig ). It is 
analogous to an analysis of covariance design for an 
individually randomised trial.6  7
In this article, we consider sample size requirements 
for cluster randomised trials with a variety of designs 
involving repeated cross sections. In particular, we 
focus on designs where the introduction of the interven-
tion is delayed for longer in some arms than others. In 
this case, we make the fundamental assumption that 
the efect of the intervention—that is, the diference in 
outcome between individuals in clusters who receive 
the intervention and individuals in clusters continuing 
to receive routine care—is the same regardless of that 
delay. Clusters must be able to provide a fresh sample of 
eligible individuals at each new cross section. We 
assume a multilevel model where the levels are clusters, 
cross sections, and individuals.
Designs for cluster randomised trials with repeated 
cross sections
Crossover versus cross forward designs
An alternative to a parallel group design is a crossover 
design in which intervention and control arms swap over 
at the end of the irst intervention period, with clusters in 
the control arm then receiving the intervention, and clus-
ters in the intervention arm returning to routine care.8 
This design would not be appropriate if there is a risk of 
“carry over” within clusters, whereby the clusters have 
supposedly been returned to routine care, but in fact con-
tinue to pass on some of the efects of the intervention to 
individuals. Nor would it be appropriate if the interven-
tion is being rolled out as part of a policy change, such as 
in the school breakfast example. In this article, we con-
sider designs where the transition is in one direction 
only, from routine care to the new intervention. These 
are sometimes known as one way crossover or unidirec-
tional crossover designs. We suggest a more simple 
description: cross forward designs.
Parallel group designs
The igure illustrates several cross forward designs. At 
the top is the parallel group design with a baseline 
assessment. Using “B” for “before intervention” and 
“A” for “after intervention,” we code the schedule of 
assessments in this case as BA in one arm and BB in the 
other (the control arm receives routine care throughout, 
and is therefore still “before intervention” at follow-up).
The baseline assessment can be discarded, leaving a 
simple parallel group design. Sample size calculations 
for this design are particularly straightforward.9 We use 
this design as a reference for comparing sample size 
requirements of other designs with repeated assess-
ments of clusters. In the igure, each design shows the 
SUMMARY POINTS
Clinical trials need a control, but if handled correctly this need not run in parallel 
with the intervention
There are various designs for cluster randomised trials involving more than one 
cross section
Multiple cross sections mean fewer clusters are required, but could result in a 
heavy burden of individual recruitment
Nevertheless, it is possible to add a cross section to a design with a single 
follow-up and reduce both the number of clusters and the number of individual 
participants needed
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relative number of clusters needed to achieve the same 
statistical power as a simple parallel group design. We 
call this the “design efect” due to repeated assessment. 
In each case, it depends only on the correlation, r, 
between two sample means from the same cluster in dif-
ferent cross sections (web appendix). Design efects are 
derived for normally distributed, continuous outcome 
measures but can also be applied to binary outcomes.10
Stepped wedge designs
If, in a parallel group design with baseline, we give the 
control clusters the intervention after the irst follow-up 
and then follow up both arms a second time, we end up 
with another kind of cross forward design: the stepped 
wedge—in this case one with two steps (ig). Stepped 
wedge designs can have any number of steps up to and 
including the total number of clusters, and deliver the 
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intervention to all clusters according to a staggered 
timetable that varies with trial arm, where “arm” now 
simply refers to a randomised group.11  12  Stepped wedge 
designs are relatively new: a recent systematic review 
found only 25 stepped wedge trials, with all but two 
published since 2000.13
Incomplete cross forward designs
Stepped wedge designs need fewer clusters than paral-
lel group designs with a single follow-up, simply 
because they assess the same clusters repeatedly. Alter-
natives such as parallel group designs with multiple 
baseline or follow-up assessments ofer a similar advan-
tage. (Among designs with a ixed number of repeated 
cross sections, the particular design which minimises 
the required number of clusters depends on the circum-
stances,12 and further research is needed.) The advan-
tage of multiple cross sections is ofset, however, by 
having to recruit a new sample of individuals each time. 
We quantify some of these sample size problems in the 
next section, but in this section we consider how we 
might reduce both the number of clusters and the num-
ber of individual participants required while increasing 
the number of cross sections. This will be worthwhile 
when trial costs are determined mostly by the numbers 
of individuals and clusters involved rather than by the 
duration of follow-up.
Incomplete cross forward designs leave gaps in the 
assessment schedule in some trial arms, requiring fewer 
individuals to be recruited.14  The simplest incomplete 
cross forward design is the dog leg, named after the 
shape made by the assessment schedule (ig).15 This 
design has no baseline assessments (that is, assessments 
at or before randomisation). Clusters in the irst arm are 
assessed after receiving the intervention, but are not 
assessed again (they may or may not continue to receive 
the intervention, depending on the context). Clusters in 
the second arm are assessed after a period of routine 
care, and assessed again after receiving the intervention. 
Clusters in the third arm receive routine care throughout, 
and are assessed once, at the second follow-up.
Elaborations to the dog leg might also be worth inves-
tigating (ig). The most obvious place in the schedule 
for an additional assessment is at the irst follow-up in 
the third arm.15 A less obvious modiication, ensuring 
that each cluster is assessed twice, is to add a baseline 
assessment (before randomisation) to the irst and third 
arms. Dog leg designs are a recent methodological 
development, and have not been used for trials so far.
Sample size calculation
The steps involved in calculating required sample size 
for a cluster randomised trial with repeated cross sec-
tions are described in table 1 . In the school breakfast 
trial,4 Murphy and colleagues wanted 80% power at the 
5% signiicance level to detect an efect size (ratio of 
mean diference to standard deviation) of 0.11 for their 
continuous outcomes. They planned to assess the out-
comes of 50 children in each cross section at each 
school, and assumed an intracluster correlation of 0.02.
We start with the sample size for an individually ran-
domised trial with simple parallel group design; using 
standard methods or tables, this is determined to be 
about 2600.16  17  The relative adjustment required for a 
cluster randomised trial—the design efect due to clus-
ter randomising—is well known in this case,9 and eval-
uates to 1.98 (table 1).
We follow Murphy and colleagues4 and assume a par-
allel group with baseline design. The next step is to cal-
culate the correlation, r, between two sample means 
from the same cluster at diferent times. This correlation 
depends on the sample size in each cluster at each cross 
section, on the intracluster correlation,9  and on the reli-
ability of the cluster population mean over time, also 
known as the cluster autocorrelation.7  Murphy and col-
leagues did not estimate a cluster autocorrelation. In 
the methodological literature, this number is some-
times assumed to be 1,11 but this assumption will under-
power repeated cross section trials when individuals 
sampled from the same cluster at diferent times are 
more heterogeneous than individuals sampled from the 
same cluster at the same time. As with the intracluster 
correlation, we could use diferent values for the cluster 
autocorrelation to see its efect on the required sample 
size, or calculate a value using similar data from com-
pleted trials. Here, we assume a cluster autocorrelation 
of 0.8, which gives r=0.4040, and the design efect due 
to repeated assessment is then 0.8368 (table 1).
We multiply our initial sample size of 2600 by the 
respective design efects due to cluster randomising and 
repeated assessment, and divide by the cluster size, giv-
ing 88 clusters in all (rounded up to a multiple of two 
since there are two arms). In each arm, we take two 
repeated cross sections of 50 children each, so that the 
total number of participants required is 8800. Table 2 
shows sample size requirements for other trial designs.
Table 1 | Steps in the calculation of sample size for a cluster randomised trial with 
repeated cross sections
Method
School breakfast  
programme example4
1. Specify values for:
 Sample size in each cluster at each cross section (m) 50
 Intracluster correlation (ρ) 0.02
 Cluster autocorrelation (π) 0.8
2. Determine from tables or by calculation:
  No of participants required for an individually randomised, 
simple parallel group design (n0)
2600
3. Choose a design for the repeated assessments Simple parallel group with baseline
4. Determine for this design:
 No of trial arms (K) 2
 Mean number of cross sections per trial arm (s)* 2
5. Calculate the following:
 Design efect due to cluster randomising (dc)† 1.98
  Correlation between two sample means from the same 
cluster at diferent times (r)‡
0.4040
 Design efect due to repeated assessment (dr)§ 0.8368
6. Required sample size is:
 No of clusters (n0×dc×dr÷m) 88 (rounded up to a multiple of K)
 No of participants (m×s×no of clusters) 8800
*As shown in the inal column in the igure.
†dc=1+(m−1)ρ.
‡r=mρπ÷dc.
§Calculated using the relevant formula from the igure, with r calculated above.
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Comparison of designs
Using the school breakfast programme example,4 the 
dog leg design requires fewer schools and fewer partici-
pants than a simple parallel group design or parallel 
group design with baseline. Murphy and colleagues pro-
posed a trial of 11 100 children in 111 schools; a dog leg 
design requires just 4200 children in 63 schools. In fact, 
a dog leg design always requires fewer clusters and 
fewer participants than a simple parallel group design, 
and likewise a dog leg with baseline always requires 
fewer clusters and fewer participants than a parallel 
group design with baseline (web appendix). Modifying 
the dog leg by adding another follow-up in the routine 
care group confers little advantage when r is moderate, 
as our example illustrates.
Risk of bias should be considered carefully with any 
design. The fundamental assumption of cross forward 
designs—that the efect of the intervention is the same if 
there is a delay following randomisation—may not 
always hold. For example, if clusters have to perform 
poorly in some sense to be eligible for the trial, they may 
show a natural improvement over time, and thus ofer 
less room for the intervention to show its efect. In 
incomplete designs, there is a risk of diferential attri-
tion of clusters in diferent arms: in a dog leg trial, for 
example, clusters in the second and third arms are fol-
lowed for longer than clusters in the irst arm, and clus-
ters in the third arm may have little contact with 
researchers during the irst follow-up period, making 
them more readily lost to follow-up. Because incomplete 
designs involve diferent patterns of assessments in dif-
ferent arms, they also assume implicitly that the pattern 
or frequency of previous assessments at cluster level 
does not inluence subsequent individual outcomes. 
Such an inluence would be unlikely since diferent indi-
viduals are assessed each time, but could arise if, for 
example, staf at a cluster changed their behaviour after 
observing assessments. In addition, if outcome data 
from multiple cross sections can be obtained at little 
cost—such as from a pre-existing anonymised data-
base—then incomplete designs lose their appeal.
Conclusions
Clinical trial designs where the same clusters of partici-
pants are assessed in more than one cross section 
(allowing intervention clusters to be compared not only 
with parallel controls but also with themselves under 
an earlier control condition) need fewer clusters than a 
trial with a single cross section, but might also need 
more participants overall. If investigators want to mini-
mise the overall number of participants and are willing 
to increase the number of cross sections, an incomplete 
design could be worth considering. A dog leg design 
run over two repeated cross sections, for example, 
needs fewer clusters and fewer participants in total 
than a trial with a single cross section.
Sample size calculations for cluster randomised tri-
als with repeated cross sections require a cluster auto-
correlation to be specified in addition to the 
intracluster correlation, and allows for variation over 
time within a cluster in addition to variation between 
clusters. Calculations that ignore the cluster autocor-
relation (such as those ignoring the intracluster cor-
relation) risk underpowering a trial. Routinely 
collected time series data, as they become more widely 
available, should help researchers quantify cluster 
autocorrelations and intracluster correlations, as well 
as highlighting secular trends in outcomes under 
 routine care.
Despite methodological challenges and risk of bias, 
eicient trial designs such as incomplete cross forward 
designs have an important role. These designs can help 
researchers meet ethical and inancial requirements to 
limit numbers of participants in research,18  as well as 
create opportunities for research in small populations 
or rare conditions.19 
We are indebted to an anonymous reviewer of a previous article who 
suggested modifying the dog leg design by adding a baseline 
assessment in two of the groups.
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Web appendix: Design efects due to repeated assess-
ment in longitudinal trial designs
